Cecilia Becattini
Cecilia Becattini publishes mostly in Cardiology and Cardiovascular Medicine, Internal Medicine and Epidemiology, on topics such as Venous Thromboembolism Diagnosis and Management, Atrial Fibrillation Management and Outcomes and Acute Ischemic Stroke Management.
- World rank
- #79,281 of 7,710,434 ranked researchers
- Rank in Italy
- #1,468 of 242,206
- Works
- 364
- Citations
- 33k
- Citations per work
- 91.0
What does Cecilia Becattini research?
Cecilia Becattini's work is mostly in Medicine (79%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences28678.7%
- Medicine28678.7%
- Everything else7821.3%
- 1Cardiology and Cardiovascular Medicine30% of their works
- 2Internal Medicine27% of their works
- 3Epidemiology7% of their works
- 4Surgery6% of their works
- 5Pulmonary and Respiratory Medicine6% of their works
- 6Hematology4% of their works
Research topics
- Venous Thromboembolism Diagnosis and Management
- Atrial Fibrillation Management and Outcomes
- Acute Ischemic Stroke Management
- Blood Coagulation and Thrombosis Mechanisms
- Acute Myocardial Infarction Research
- Central Venous Catheters and Hemodialysis
- COVID-19 Clinical Research Studies
- Heparin-Induced Thrombocytopenia and Thrombosis
Which keywords describe Cecilia Becattini's research?
The keywords of their largest research topics: Risk Factors, Antithrombotic Therapy, Diagnosis, Pulmonary Embolism, Venous Thromboembolism, Guidelines, Anticoagulant Therapy and Atrial Fibrillation.
- Vaccination
- SARS-CoV-2
- Central Venous Catheterization
- Myocardial Infarction
- Thrombin
- Thrombosis
- Thrombolysis
- Atrial Fibrillation
- Guidelines
- Pulmonary Embolism
- Antithrombotic Therapy
- Risk Factors
- Diagnosis
- Venous Thromboembolism
- Anticoagulant Therapy
- Ischemic Stroke
- Immune Response
- Protease-Activated Receptors
- Acute Coronary Syndromes
- Catheter-Related Infections
- Clinical Characteristics
- Heparin-Induced Thrombocytopenia
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 22 words, with their numbers
- Risk Factors3022 topics
- Antithrombotic Therapy2902 topics
- Diagnosis2782 topics
- Pulmonary Embolism2591 topic
- Venous Thromboembolism2591 topic
- Guidelines2052 topics
- Anticoagulant Therapy1801 topic
- Atrial Fibrillation1801 topic
- Ischemic Stroke431 topic
- Thrombolysis431 topic
- Immune Response392 topics
- Thrombosis392 topics
- Protease-Activated Receptors311 topic
- Thrombin311 topic
- Acute Coronary Syndromes251 topic
- Myocardial Infarction251 topic
- Catheter-Related Infections211 topic
- Central Venous Catheterization211 topic
- Clinical Characteristics201 topic
- SARS-CoV-2201 topic
- Heparin-Induced Thrombocytopenia191 topic
- Vaccination191 topic
Where does Cecilia Becattini work?
Cecilia Becattini's main affiliation in the publication record is University of Perugia, Italy.
How many publications and citations does Cecilia Becattini have?
OpenAlex counts 364 works and 33,115 citations for Cecilia Becattini, an h-index of 65, ranking #79,281 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Cecilia Becattini. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.